Company news
Formosa Laboratories, Inc. (TWSE:4746) news
Formosa Laboratories, Inc. news releases on 6ix. Latest, Apr 30, 2026: Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance…
Press releases & updates
Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases
April 30, 2026
Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
February 23, 2026
Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
January 12, 2026
Formosa Pharmaceuticals Announces Licensing Agreement with Rxilient, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
December 3, 2025
Formosa Plastics Corporation, U.S.A. Unveils the Largest Horizontal Polypropylene Reactor in North America
September 23, 2025
PAK Quality Foods Has Acquired Formosa Foods
July 21, 2025